Hogan Lovells advises on the HK$400 million IPO of Sinohealth Holdings Limited

Press releases | 13 July 2022

Hong Kong, 13 July 2022 – Global law firm Hogan Lovells acted for the sole sponsor, BNP Paribas Securities (Asia) Limited, and the underwriters, in the HK$400 million Initial Public Offering (IPO) of Sinohealth Holdings Limited on the Main Board of the Hong Kong Stock Exchange.

Sinohealth Holdings Limited is a leading healthcare insight solutions provider in China. It primarily provides integrated healthcare insight solutions including data insight solutions, data-driven publications and events and SaaS products to its multinational and domestic medical product manufacturer clients, based on healthcare big data and associated technologies.

The underwriters were BNP Paribas Securities (Asia) Limited, CCB International Capital Limited, Orient Securities (Hong Kong) Limited, Haitong International Securities Company Limited, UOB Kay Hian (Hong Kong) Limited, Guotai Junan Securities (Hong Kong) Limited, Eddid Securities and Futures Limited, Zhongtai International Securities Limited, Futu Securities International (Hong Kong) Limited, Innovax Securities Limited, Fosun Hani Securities Limited and Livermore Holdings Limited.

Hong Kong corporate partner Nelson Tang led the Hogan Lovells team, with support from senior associates Jeffrey Lee and Jessica Shing, senior paralegal Ruby Wang and paralegal Pamela Pang.